Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines

Pediatric Infectious Disease Journal

Volumn 29, Issue 10, 2010, Pages 919-923

  Moon, Sung Sil ^a   Wang, Yuhuan ^a   Shane, Andi L ^b   Nguyen, Trang ^c   Ray, Pratima ^d   Dennehy, Penelope ^e   Baek, Luck Ju ^f   Parashar, Umesh ^a   Glass, Roger I ^g   Jiang, Baoming ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

^d ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^e RHODE ISLAND HOSPITAL   (United States)

^f Korea University College of Medicine   (South Korea)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

breast milk; neutralizing activity; rotavirus; RV1; RV5

Indexed keywords

IMMUNOGLOBULIN A; ROTAVIRUS VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; BREAST FEEDING; BREAST MILK; FEMALE; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; INFANT; PRIORITY JOURNAL; ROTAVIRUS INFECTION; TREATMENT OUTCOME; VIRUS INFECTIVITY;

EID: 77955893909     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181e232ea     Document Type: Article

References (26)

1. Parashar UD, Gibson CJ, Bresse JS, et al. Rotavirus and severe childhood diarrhea. Emerg Infect Dis. 2006;12:304-306. (Pubitemid 43297101)
2. World Health Organization. Rotavirus vaccines. Wkly Epidemiol Rec. 2007;82:285-295.
3. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22. (Pubitemid 43048947)
4. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23-33. (Pubitemid 43048948)
5. Vesikari T, Karvonen A, Puustinen L, et al. Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants. Pediatr Infect Dis J. 2004;23:937-943. (Pubitemid 40812781)
6. Salinas B, Perez Schael I, Linhares AC, et al. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants. Pediatr Infect Dis J. 2005;24:807-816. (Pubitemid 41324890)
7. Steele AD, De Vos B, Tumbo J, et al. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines. Vaccine. In press.
8. Zaman K, Sack DA, Yunus M, et al. Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. Vaccine. 2009;27:1333-1339.
9. Narang A, Bose A, Pandit AN, et al. Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants. Hum Vaccin. 2009;5:414-419.
10. Meeting of the immunization Strategic Advisory Group of Experts, April 2009-conclusions and recommendations. Wkly Epidemiol Rec 2009;84:220-236.
11. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362: 289-298.
12. Patel M, Pedreira C, De Oliveira LH, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA. 2009;301:2243-2251.
13. Gunn RA, Kimball AM, Pollard RA, et al. Bottle feeding as a risk factor for cholera in infants. Lancet. 1979;2:730-732.
14. John TJ, Devarajan LV, Luther L, et al. Effect of breast-feeding on seroresponse of infants to oral poliovirus vaccination. Pediatrics. 1976;57: 47-53.
15. Hanlon P, Hanlon L, Marsh V, et al. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet. 1987;1:1342-1345. (Pubitemid 17076248)
16. De Mol P, Zissis G, Butzler JP, et al. Failure of live, attenuated oral rotavirus vaccine. Lancet. 1986;2:108. (Pubitemid 16097112)
17. Lanata CF, Black RE, del Aguila R, et al. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. J Infect Dis. 1989; 159:452-459. (Pubitemid 19065891)
18. Ray PG, Kelkar SD. Prevalence of neutralizing antibodies against different rotavirus serotypes in children with severe rotavirus-induced diarrhea and their mothers. Clin Diagn Lab Immunol. 2004;11:186-194.
19. Glass RI, Stoll BJ, Wyatt RG, et al. Observations questioning a protective role for breast-feeding in severe rotavirus diarrhea. Acta Paediatr Scand. 1986;75:713-718.
20. Glass RI, Ing DJ, Stoll BJ, et al. Immune response to rotavirus vaccines among breast-fed and nonbreast-fed children. Adv Exp Med Biol. 1991;310: 249-254.
21. Jiang B, Estes MK, Barone C, et al. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles. Vaccine. 1999;17: 1005-1013. (Pubitemid 29074757)
22. Jiang B, Wang Y, Saluzzo JF, et al. Immunogenicity of a thermally inactivated rotavirus vaccine in mice. Hum Vaccin. 2008;4:143-147. (Pubitemid 351881183)
23. Patel M, Shane AL, Parashar UD, et al. Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis. 2009;200(suppl 1):S39-S48.
24. Steele AD, De Vos B, Tumbo J, et al. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines. Vaccine. In press.
25. Van Man N, Luan le T, Trach DD, et al. Epidemiological profile and burden of rotavirus diarrhea in Vietnam: 5 years of sentinel hospital surveillance, 1998-2003. J Infect Dis. 2005;192(suppl 1):S127-S132.
26. Jiang B, Gentsch JR, Glass RI. Inactivated rotavirus vaccines: a priority for accelerated vaccine development. Vaccine. 2008;26:6754-6758.